Trial intelligence / Profile preview

Clofibrate prophylaxis for prevention of jaundice in very low birth weight twin neonates

IRCT138811061162N15Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of clofibride in neonatal hyperbilirubinemia (2 arms), sponsored by Mashhad University of Medical Sciences. Started Sep 2010; status: completed.

02

Drugs

clofibride
03

Conditions

neonatal hyperbilirubinemia

Beyond the preview

Go deeper on IRCT138811061162N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138811061162N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call